Detalhe da pesquisa
1.
Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects.
Mol Cancer;
23(1): 56, 2024 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38491381
2.
Immune-restoring CAR-T cells display antitumor activity and reverse immunosuppressive TME in a humanized ccRCC mouse model.
iScience;
27(2): 108879, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38327771
3.
The B7:CD28 family and friends: Unraveling coinhibitory interactions.
Immunity;
57(2): 223-244, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38354702
4.
PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients.
Clin Cancer Res;
30(4): 803-813, 2024 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38060202
5.
Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy.
Cell Chem Biol;
31(4): 776-791.e7, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37751743
6.
Regulation of HHLA2 expression in kidney cancer and myeloid cells.
BMC Cancer;
23(1): 1039, 2023 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37891555
7.
Formate Supplementation Enhances Antitumor CD8+ T-cell Fitness and Efficacy of PD-1 Blockade.
Cancer Discov;
13(12): 2566-2583, 2023 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37728660
8.
The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy.
Front Immunol;
14: 1237715, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37771579
9.
PD-1 blockade increases the self-renewal of stem-like CD8 T cells to compensate for their accelerated differentiation into effectors.
Sci Immunol;
8(86): eadg0539, 2023 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37624909
10.
Inverse relationship between Fusobacterium nucleatum amount and tumor CD274 (PD-L1) expression in colorectal carcinoma.
Clin Transl Immunology;
12(8): e1453, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37538192
11.
Novel Antimurine Thyroid-Stimulating Hormone Receptor Monoclonal Antibodies.
Monoclon Antib Immunodiagn Immunother;
42(3): 109-114, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37343169
12.
Publisher Correction: Targeting PD-L2-RGMb overcomes microbiome-related immunotherapy resistance.
Nature;
618(7966): E27, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37264079
13.
ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy.
Nat Commun;
14(1): 2859, 2023 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208329
14.
Targeting PD-L2-RGMb overcomes microbiome-related immunotherapy resistance.
Nature;
617(7960): 377-385, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37138075
15.
PRMT1 mediated methylation of cGAS suppresses anti-tumor immunity.
Nat Commun;
14(1): 2806, 2023 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37193698
16.
PI3Kß controls immune evasion in PTEN-deficient breast tumours.
Nature;
617(7959): 139-146, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37076617
17.
mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion.
Nat Commun;
14(1): 1214, 2023 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869048
18.
Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models.
Proc Natl Acad Sci U S A;
120(6): e2219199120, 2023 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36724255
19.
STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer.
J Immunother Cancer;
11(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36609487
20.
mTOR regulates T cell exhaustion and PD-1-targeted immunotherapy response during chronic viral infection.
J Clin Invest;
133(2)2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36378537